PPT-Chronic Kidney Disease: Detection and Management in Primary Care

Chronic Kidney Disease Detection and Management in Primary Care Julia Scialla MD MHS FASN Associate Professor of Medicine and Public Health Sciences University of Virginia Adjunct Associate Professor of Medicine. Aging. The 21. st. Century. . Healthcare . Challenge . Howard Bergman, . MD, FCFP, FRCPC. Chair, Department of Family Medicine. Professor . of Family . Medicine, Medicine and . Oncology. The . Dr. Joseph Kaufmann . How to involve people with diabetes and CKD in their own . care . –. what information must they have to manage their own condition effectively?. Objectives and background for this learning resource. Kevin Harley, M.D.. Assistant Clinical Professor. Department of Medicine. Division of Nephrology & Hypertension. UC Irvine Medical Center. Objectives. Review Definition of CKD and its classification. Learning Objectives. Facilitate timely testing and intervention in patients at-risk for chronic kidney disease (CKD).. Apply appropriate . clinical measures . to manage risk and increase . patient . safety in CKD.. Epidemiology. CKD affects about 26 million people in the US. Approximately 19 million adults are in the early stages of the disease . On the rise do to increasing prevalence of diabetes and hypertension. Epidemiology. CKD affects about 26 million people in the US. Approximately 19 million adults are in the early stages of the disease . On the rise do to increasing prevalence of diabetes and hypertension. Dr. T. A. L. . Dlamini. Specialist Physician and . Nephrologist. Talk overview . Kidney function. Assessing kidney function. Chronic kidney disease (CKD). Benefits of early detection . Conclusion and take home message . Andrew . Narva. , MD, FASN & . Amy Barton . Pai. , PharmD, MHI, FASN, FCCP, FNKF. Andrew . Narva. , MD, FASN. No financial disclosures/conflicts of interest. Amy Barton . Pai. , PharmD, MHI, FASN, FCCP, FNKF. Namita Singh, MD, FASN. Year 2021. DISCLOSURES. I have no financial relationships with commercial interests to disclose.. This presentation does not include discussion of off-label or investigational use. . Chronic . c. are . Training . For . district . hospital . Nurses . in . Rwanda . 2013. Session 1: Defining chronic kidney disease. By the end of this Session, participants will be able to:. Screen for chronic kidney disease. . Structural . or functional abnormalities of the kidneys for . >. 3 months. . from early to late-stage disease, . Chronic Kidney Disease. as . manifested by either:. 1. Kidney . damage, with or without decreased GFR, as . Stuart M. c. Adam, MD, FRCPC. General Internal Medicine. The Moncton Hospital. April 2022. Conflicts of Interest. Nothing to disclose. 2. Objectives. Describe an approach to the work-up of chronic kidney disease (CKD). disease A discussion paper for building resilience and sustainability of healthcare systems International Society of Nephrology March 2021 2 About this discussion paper This discussion paper has Quality Department Guidelines for Clinical Care Ambulatory Chronic Kidney Disease Guideline Team Team Leader Jennifer Reilly Lukela, MD General MedicineTeam MembersR. Van Harrison, PhDMedical Educati